An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
The combination therapy which has been proposed as the strategy for the cancer treatment
could achieve a synergistic effect for cancer therapies and reduce the dosage of the applied …
could achieve a synergistic effect for cancer therapies and reduce the dosage of the applied …
[HTML][HTML] PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy
M Yousefnezhad, S Davaran, M Babazadeh… - BioImpacts …, 2023 - ncbi.nlm.nih.gov
PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for
prostate cancer using a drug repurposing strategy - PMC Back to Top Skip to main content NIH …
prostate cancer using a drug repurposing strategy - PMC Back to Top Skip to main content NIH …
[HTML][HTML] Mode of photoexcited C60 fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells
An external file that holds a picture, illustration, etc. Object name is bi-9-211-g004. jpg
Introduction: C 60 fullerene has received great attention as a candidate for biomedical …
Introduction: C 60 fullerene has received great attention as a candidate for biomedical …